Suppr超能文献

生活方式干预通过改变代谢综合征患者的肠道微生物群来改善脂蛋白谱和代谢内毒素血症。

Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome.

机构信息

Departamento de Fisiología de la Nutrición Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico.

Centro de Ciencias de la Complejidad Universidad Nacional Autónoma de México Mexico City Mexico.

出版信息

J Am Heart Assoc. 2019 Sep 3;8(17):e012401. doi: 10.1161/JAHA.119.012401. Epub 2019 Aug 27.

Abstract

Background Metabolic syndrome (MetS) is a serious health problem over the world; thus, the aim of the present work was to develop a lifestyle intervention to decrease the dysbiosis of gut microbiota and reduce the biochemical abnormalities of MetS. Methods and Results The prevalence of MetS was evaluated in 1065 subjects of Mexico City, Mexico, and the gut microbiota in a subsample. Subjects with MetS were selected for a pragmatic study based on a lifestyle intervention with a low-saturated-fat diet, reduced-energy intake, with functional foods and physical activity, and a second group was selected for a randomized control-placebo study to assess the gut microbiota after the dietary intervention. Prevalence of MetS was 53%, and the higher the body mass index, the higher the gut microbiota dysbiosis. The higher the Homeostatic Model Assessment for Insulin Resistance, the lower the high-density lipoprotein cholesterol concentration. The pragmatic study revealed that after 15 days on a low-saturated-fat diet, there was a 24% reduction in serum triglycerides; and after a 75-day lifestyle intervention, MetS was reduced by 44.8%, with a reduction in low-density lipoprotein cholesterol, small low-density lipoprotein particles, glucose intolerance, lipopolysaccharide, and branched-chain amino acid. The randomized control-placebo study showed that after the lifestyle intervention, there was a decrease in the dysbiosis of the gut microbiota associated with a reduction in the Prevotella/ Bacteroides ratio and an increase in the abundance of Akkermansia muciniphila and Faecalibacterium prausnitzii. Conclusions A lifestyle intervention significantly decreased MetS components, small low-density lipoprotein particle concentration, gut microbiota dysbiosis, and metabolic endotoxemia, reducing the risk of atherosclerosis. Clinical Trial Registration URL: https://www.clinicaltrials.gov. Unique identifier: NCT03611140.

摘要

背景

代谢综合征(MetS)是全球范围内的严重健康问题;因此,本研究旨在开发一种生活方式干预措施,以减少肠道微生物群的失调,降低 MetS 的生化异常。

方法和结果

在墨西哥城的 1065 名受试者中评估了 MetS 的患病率,并对其中的一部分进行了肠道微生物组研究。选择有 MetS 的受试者进行基于低饱和脂肪饮食、减少能量摄入、功能性食品和体力活动的生活方式干预的实用研究,以及另一组随机对照安慰剂研究,以评估饮食干预后的肠道微生物组。MetS 的患病率为 53%,体重指数越高,肠道微生物组失调越严重。稳态模型评估胰岛素抵抗越高,高密度脂蛋白胆固醇浓度越低。实用研究表明,在低饱和脂肪饮食 15 天后,血清甘油三酯降低了 24%;在 75 天的生活方式干预后,MetS 降低了 44.8%,同时降低了低密度脂蛋白胆固醇、小而密的低密度脂蛋白颗粒、葡萄糖耐量、内毒素、支链氨基酸。随机对照安慰剂研究表明,生活方式干预后,肠道微生物组的失调减少,与 Prevotella/ Bacteroides 比值降低和 Akkermansia muciniphila 和 Faecalibacterium prausnitzii 丰度增加有关。

结论

生活方式干预显著降低了 MetS 成分、小而密的低密度脂蛋白颗粒浓度、肠道微生物组失调和代谢性内毒素血症,降低了动脉粥样硬化的风险。

临床试验注册网址

https://www.clinicaltrials.gov。

唯一标识符

NCT03611140。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/6755842/231f8b3e4c73/JAH3-8-e012401-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验